Veran Medical Technologies has developed and commercialized a next-generation electromagnetic thoracic navigation platform called the SPiN Thoracic Navigation System. It is the first and only technology that enables Pulmonologists or Thoracic Surgeons to accurately access lung nodules outside of an airway using a navigated transthoracic needle.
Olympus Corporation today announced that it has entered into an agreement to acquire Veran Medical Technologies, a leading provider of advanced medical devices specializing in interventional pulmonology, for up to USD 340 million. The acquisition will be the latest in a series of strategic acquisitions designed to strengthen Olympus’ position as a leading global medical device company.
We are proud to be joining forces with Olympus, a company with a 100-year legacy and a global reputation for quality, leadership and innovation. Olympus has a clear strategy to become a global medtech leader, and we’re excited to contribute our unique capabilities and become part of this journey.
- Jason Pesterfield / CEO, Veran